Committed to Our Clients’ Success

Are you or your clients negatively impacted by current market conditions like rising interest rates, increased costs, and valuation reductions in the public capital markets? If so, you may have...

Because many early-stage life sciences companies do not yet have revenue, valuing them has always been challenging. These challenges have been amplified by the spotlight put on the industry by...